Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery

Lab Chip. 2020 Aug 7;20(15):2788-2795. doi: 10.1039/d0lc00567c. Epub 2020 Jul 7.

Abstract

A novel production process flow is presented here for the manufacture of hollow silicon microneedles using deep reactive-ion etching (DRIE) technology. The patent-pending three-step process flow has been developed to produce multiple arrays of sharp-tipped, hollow microneedles, which facilitate easy insertion and controlled fluid injection into excised skin samples. A bevelled tip and vertical sidewalls for the microneedle have been achieved with good uniformity, despite >45% open etch area. Processing steps and etch challenges are discussed, and preliminary skin testing results are presented, showing effective needle insertion and delivery of fluorescent dye into ex vivo skin from human breast tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Drug Delivery Systems*
  • Humans
  • Microinjections*
  • Needles
  • Pharmaceutical Preparations*
  • Plasma
  • Silicon*
  • Technology

Substances

  • Pharmaceutical Preparations
  • Silicon